Centre for Antibiotic Allergy & Research
@CAAR_Aus
Followers
919
Following
1K
Media
63
Statuses
756
@TheDohertyInst Research group led by @TrubianoJason - novel diagnostics, #antibioticallergy delabeling & @aus_scar - collaborators @ID_austin @austin_health
Austin Health (Melbourne, Australia)
Joined May 2018
🆕💫Systematic review and meta-analysis 33 studies, including 6 RCTs and 27 observational Impact of antibiotic duration in management of diabetic foot osteomyelitis. Duration: ≤6 weeks Vs >6 weeks DFO is heterogeneous disease imho! #IDXposts
https://t.co/PceTzkuSMS
1
24
64
🆕💫Prospective cohort study @TrubianoJason @CMIComms The long-term sustainability of a pharmacist-led antimicrobial stewardship penicillin allergy delabelling ward round #IDXposts
https://t.co/eNblMFsxLp
2
9
40
Read the insightful EDITORIAL by Sara Vogrin, Kimberly G. Blumenthal, and Jason A. Trubiano about the article “Comparative performance of four penicillin allergy prediction strategies in a large cohort ” published in the November issue
0
2
5
SC delivery of antibiotics is a practical alternative to IV administration 🆕️⚡️⚡️#JAC @jasonroberts_pk SC meropenem appears to be well tolerated w favourable PK profile Either 1.5 g twice daily or 3 g as a 24h SC infusion considered for future evaluation
academic.oup.com
AbstractBackground. Subcutaneous delivery of antibiotics is a practical alternative to IV administration. Meropenem is commonly used to treat infections ca
2
21
70
🌏 What an incredible event! Over 200 attendees from 10 countries joined the 2024 Drug Hypersensitivity Symposium hosted by @TheDohertyInst, @AustinHealth and @CAAR_Aus. 15 lightning talks highlighted the latest advancements in drug allergy research. We were privileged to hear
1
4
14
NAAN is thrilled to launch "Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network", a multidisciplinary collaborative effort to aid implementation of #penicillinallergy #AMS programs!
onlinelibrary.wiley.com
Penicillin allergy is a significant burden on patient, prescribing and hospital outcomes. There has been increasing interest in the incorporation of penicillin allergy testing (i.e. delabelling)...
0
8
20
🚨 2️⃣ PhD opportunities with us in Melbourne @CAAR_Aus @TheDohertyInst 👇 1️⃣ PhD examining RCT validation of clinical decision rules in antibiotic allergy - beyond #PENFAST 2️⃣ PhD examining prolonged oral challenge in #penicillinallergy - #PROSPECTOR2 study Suited to
3
8
15
Meet Alex Wadelton! This Fri and Sat he's aiming to set a WORLD RECORD for the most lengths of a cricket pitch run in 24 hrs in full cricket gear🏏 🏃♂️ All💰raised will go to @NACEresearch for research into #allergies & #anaphylaxis, which his cricket-mad son Roarke has 🔗 below!
1
6
6
Don't miss out on #DHS2024 @TheDohertyInst !! 🚨Breaking news @CAAR_Aus 🚨 ➡️> 10 New #drugallergy Data Abstracts ➡️ New data on the latest member of the #PENFAST "family" ➡️Launch of a @NAAN_Aus Inpatient Penicillin Allergy Guide in #AMS ➡️Launch of new Antibiotic Allergy
0
10
18
Thank you @McGill_DOM for your support in our #QI research on the #Quality of life in patients with #drug #hypersensitivity reactions - We are looking forward to demonstrating the benefit of drug allergy investigations on our patient’s quality of life @AllergyMuhc @cusm_muhc
0
1
3
#DHS2024 (🇦🇺 25-27 Oct) - Day 2 hosted by @NAAN_Aus. #antibioticallergy DOC, periop, digital health, novel approaches, iNAAN data & #PENFAST tools! @Elise_Mitri @neilthepcist @LouiseSavic @AnaCopaescu @drwinnietong @JonnyPeter7 @TrubianoJason...! Register: https://t.co/HGq7MHP0Ls
0
6
12
#DHS2024 (🇦🇺 25-27 Oct) - Day 1 hosted by @aus_scar. Highlights #SCAR diagnostics, risk-prediction, novel therapies, genomic prediction & case discussion. @vumc_cdsi_rsch @rannakoe2 @TrubianoJason @DermatologyACD @NACEresearch @TheDohertyInst Register👇 https://t.co/yI73CkJNB7
eventbrite.com.au
#DHS2024 is 3-day hybrid symposium of local & international multidisciplinary experts across drug allergy science and clinical practice
1
3
9
#DHS2024 (🇦🇺 25-27 Oct) - Day 3 hosted by @CAAR_Aus - #drugallergy & #anaphylaxis bonanza! Periop IV challenges, hidden allergens, contrast, NSAID allergy, chemo allergy. @LouiseSavic @DrJoeDeluca @allisoncramsey @TheDohertyInst @NACEresearch Register: https://t.co/HGq7MHOsVU
0
1
2
#DHS2024 (🇦🇺 25-27 Oct) - Day 2 hosted by @NAAN_Aus. #antibioticallergy DOC, periop, digital health, novel approaches, iNAAN data & #PENFAST tools! @Elise_Mitri @neilthepcist @LouiseSavic @AnaCopaescu @drwinnietong @JonnyPeter7 @TrubianoJason...! Register: https://t.co/HGq7MHP0Ls
0
6
12
#DHS2024 (🇦🇺 25-27 Oct) - Day 1 hosted by @aus_scar. Highlights #SCAR diagnostics, risk-prediction, novel therapies, genomic prediction & case discussion. @vumc_cdsi_rsch @rannakoe2 @TrubianoJason @DermatologyACD @NACEresearch @TheDohertyInst Register👇 https://t.co/yI73CkJNB7
eventbrite.com.au
#DHS2024 is 3-day hybrid symposium of local & international multidisciplinary experts across drug allergy science and clinical practice
1
3
9
🚨🚨#DHS2024 (25-27th October 2024 - Melbourne 🇦🇺) Abstract Submission Closing soon! Get your latest #drugallergy research in! Amazing opportunity to share #SCAR #penicillinallergy #antibioticallergy #perioperativeallergy research - Lots of oral abstract spots on offer!
0
4
8
Proud of the collective will of many to get the first national experience of #SCAR in Australia 🇦🇺 published - #DRESS and #antibioticallergy predominance. A long way to go in terms of prevention and diagnosis! Thanks to all the collaborators 👏@aus_scar @CAAR_Aus @Austin_Health
0
8
26
A great way for the #drugallergy community to connect at #DHS2024. Now with heavily discounted virtual rego for 🌎 LMIC clinicians! @TheDohertyInst @TrubianoJason
It’s World Allergy Week! Are you registered to attend the 2024 Drug Hypersensitivity Symposium? Join the discussion across drug allergy science and clinical practice OCT 25-27. Register 👉 https://t.co/lyMhHrDQkm
@UniMelbMDHS @TheRMH @Austin_Health @CAAR_Aus @TrubianoJason
0
1
4
"Do it your self...FAST"..... Penicillin & Sulfa allergy self-assessment. Could be a gamechanger in risk stratifying patients into low-risk delabelling clinics. Well done 👏 Dr Morgan Rose @CAAR_Aus @Austin_Health @NCICancer @TheDohertyInst
pubmed.ncbi.nlm.nih.gov
Validation of a digital self-assessment to identify low-risk penicillin and sulfa antibiotic allergies in adults (SELF-FAST)
1
8
34